FDA cites Mark Cuban's drug compounding center in Dallas with sterility, quality concerns

The FDA is raising sterility and other quality concerns with Mark Cuban's Cost Plus Drugs compounding facility in Dallas, following a nine-day inspection of the site in August and September. A